Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial thiol-containing residues, primarily the sulfhydryl (-SH) groups found on cysteine amino acids, are essential functional components of numerous bacterial, fungal, and viral proteins. These residues are critical for maintaining the tertiary structure of proteins through disulfide bridge formation and are often found within the active sites of metabolic enzymes, such as dehydrogenases, where they facilitate catalysis (McDonnell & Russell, 1999, Clinical Microbiology Reviews). Additionally, thiols play a central role in microbial redox homeostasis, protecting cells from oxidative stress through molecules like glutathione or mycothiol (Slavin et al., 2017, Journal of Nanobiotechnology). Many broad-spectrum antiseptics and disinfectants exploit the high reactivity of these groups; for instance, silver ions (Ag+) have a high affinity for thiols, binding to them to cause immediate protein dysfunction and cell death (Finnegan & Percival, 2015, Journal of Wound Care). Oxidizing agents like povidone-iodine also target these residues, converting them into inactive forms and disrupting the microbial cell membrane and internal machinery (Bigliardi et al., 2017, International Journal of Surgery). While highly effective as topical treatments, the therapeutic challenge lies in the potential for these agents to also react with host thiol groups, necessitating careful concentration management to avoid cytotoxicity.
Antimicrobial agents target these residues through covalent binding (mercaptide formation with heavy metals) or oxidation (conversion of thiols to disulfides or sulfenic/sulfonic acids), leading to protein denaturation and enzyme inactivation.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial thiol-containing residues (-SH groups).